LoginSignup
Resmed logo

Resmed

Stock
Stock
ISIN: US7611521078
Ticker: RMD
US7611521078
RMD

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Resmed has so far distributed $2.02 in 2024. The next dividend will be paid on 14.03.2025

$1.411

CHART BY

Frequently asked questions

What is Resmed's market capitalization?

The market capitalization of Resmed is $34.83B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Resmed's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Resmed is 31.45. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Resmed?

Resmed's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $7.543. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Resmed's stock?

Currently, 24 analysts cover Resmed's stock, with a consensus target price of $259.55. Analyst ratings provide insights into the stock's expected performance.

What is Resmed's revenue over the trailing twelve months?

Over the trailing twelve months, Resmed reported a revenue of $4.81B.

What is the EBITDA for Resmed?

Resmed's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.70B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Resmed?

Resmed has a free cash flow of $1.35B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Resmed have, and what sector and industry does it belong to?

Resmed employs approximately 9,980 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Resmed's shares?

The free float of Resmed is 145.64M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$34.83B
EPS (TTM) 
$7.543
Free Float 
145.64M
P/E ratio (TTM) 
31.45
Revenue (TTM) 
$4.81B
EBITDA (TTM) 
$1.70B
Free Cashflow (TTM) 
$1.35B

Pricing

1D span
$229.90$238.57
52W span
$164.29$260.00

Analyst Ratings

The price target is $259.55 and the stock is covered by 24 analysts.

Buy

15

Hold

8

Sell

1

Information

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Employees
9,980
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US7611521078
Primary Ticker
RMD

Knockouts

Join the conversation
Sign upLogin